Metabolic Background Determines the Importance of NOS3 Polymorphisms in Restenosis after Percutaneous Coronary Intervention: A Study in Patients with and without the Metabolic Syndrome

Ítems similars

• Matrix Metalloproteinases 2 and 3 Gene Polymorphisms and the Risk of Target Vessel Revascularization after Percutaneous Coronary Intervention: Is There Still Room for Determining Genetic Variation of MMPs for Assessment of an Increased Risk of Restenosis?
  per: Verschuren, J.J.W., et al.
  Publicat: (2010)
• A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention
  per: Sampietro, M. Lourdes, et al.
  Publicat: (2011)
• Ten-year mortality risk of patients undergoing elective PCI: long-term follow-up of the GENetic Determinants of Restenosis (GENDER) study: No increased mortality risk by restenosis, only by coronary artery disease itself
  per: Verschuren, J. J. W., et al.
  Publicat: (2012)
• Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and Mortality
  per: Trompet, Stella, et al.
  Publicat: (2011)
• Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and Mortality
  per: Stella Trompet, et al.
  Publicat: (2011-01-01)